{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T20:15:22Z","timestamp":1793304922900,"version":"4.5.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2005,8,1]],"date-time":"2005-08-01T00:00:00Z","timestamp":1122854400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2005,8,1]],"date-time":"2005-08-01T00:00:00Z","timestamp":1122854400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Urol Rep"],"published-print":{"date-parts":[[2005,8]]},"DOI":"10.1007\/s11934-005-0029-y","type":"journal-article","created":{"date-parts":[[2007,6,5]],"date-time":"2007-06-05T18:56:25Z","timestamp":1181069785000},"page":"307-312","source":"Crossref","is-referenced-by-count":47,"title":["Prostatitis and serum prostate-specific antigen"],"prefix":"10.1007","volume":"6","author":[{"given":"Puneet","family":"Sindhwani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher M.","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"29_CR1","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/S0094-0143(05)70374-8","volume":"24","author":"MN Tchetgen","year":"1997","unstructured":"Tchetgen MN, Oesterling JE: The effects of prostatitis, urinary retention, ejaculation, and ambulation on the serum prostate specific antigen concentration. Urol Clin North Am 1997, 24:283\u2013291.","journal-title":"Urol Clin North Am"},{"key":"29_CR2","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1046\/j.1464-410X.1997.06723.x","volume":"79","author":"CA Heman-Ackah","year":"1997","unstructured":"Heman-Ackah CA, Festenstein JB, Hibbert P, et al.: Experience with an assay for prostate-specific antigen and transrectal ultrasonography in the diagnosis of prostate cancer. Br J Urol 1997, 79:439\u2013444.","journal-title":"Br J Urol"},{"key":"29_CR3","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1016\/S0022-5347(17)35304-1","volume":"151","author":"DW Keetch","year":"1994","unstructured":"Keetch DW, Catalona WJ, Smith DS: Serial prostatic biopsies in men with persistently elevated serum PSA values. J Urol 1994, 151:1571\u20131574.","journal-title":"J Urol"},{"key":"29_CR4","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1001\/jama.270.8.948","volume":"270","author":"WJ Catalona","year":"1993","unstructured":"Catalona WJ, Smith DS, Ratliff TL, Basler JW: Detection of organconfined prostate cancer is increased through prostate-specific antigen-based screening. JAMA 1993, 270:948\u2013954.","journal-title":"JAMA"},{"key":"29_CR5","volume-title":"Pathogenesis and Treatment of Urinary Tract Infections","author":"TA Stamey","year":"1980","unstructured":"Stamey TA: Pathogenesis and Treatment of Urinary Tract Infections. Baltimore: Williams and Wilkins; 1980."},{"key":"29_CR6","first-page":"492","volume":"5","author":"EM Mears","year":"1968","unstructured":"Mears EM, Stamey TA: Bacteriologic localization patterns in bacterial prostatitis and urethritis. Investig Urol 1968, 5:492\u2013518.","journal-title":"Investig Urol"},{"key":"29_CR7","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/S0090-4295(98)00297-0","volume":"52","author":"JC Nickel","year":"1998","unstructured":"Nickel JC, Nigro M, Valiquette L, et al.: Diagnosis and treatment of prostatitis in Canada. Urology 1998, 52:797\u2013802.","journal-title":"Urology"},{"key":"29_CR8","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.1016\/S0022-5347(17)31662-2","volume":"152","author":"ET Wright","year":"1994","unstructured":"Wright ET, Chimel JS, Grayback JT, et al.: Prostatic fluid inflammation in prostatitis. J Urol 1994, 152:2300\u20132308.","journal-title":"J Urol"},{"key":"29_CR9","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1002\/pros.2990200205","volume":"20","author":"DE Neal Jr","year":"1992","unstructured":"Neal DE Jr, Clejan S, Sarma D, Moon TD: Prostate-specific antigen and prostatitis I: effect of prostatitis on serum PSA in the human and nonhuman primate. Prostate 1992, 20:105\u2013111.","journal-title":"Prostate"},{"key":"29_CR10","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1002\/1097-0142(19911001)68:7<1592::AID-CNCR2820680721>3.0.CO;2-M","volume":"68","author":"PN Brawn","year":"1991","unstructured":"Brawn PN, Speights VO, Kuhl D, et al.: Prostate-specific antigen levels from completely sectioned, clinically benign whole prostates. Cancer 1991, 68:1592\u20131599.","journal-title":"Cancer"},{"key":"29_CR11","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/0090-4295(94)90225-9","volume":"43","author":"T Bjork","year":"1994","unstructured":"Bjork T, Bjartell A, Abrahamsson PA, et al.: Alpha-1-antichymotrypsin production in PSA-producing cells is common in prostate cancer but rare in benign prostatic hyperplasia. Urology 1994, 43:427\u2013434.","journal-title":"Urology"},{"key":"29_CR12","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1001\/jama.274.15.1214","volume":"274","author":"WJ Catalona","year":"1995","unstructured":"Catalona WJ, Smith DS, Wolfert RL, et al.: Evaluation of percentage of free serum prostate-specific antigen to improve specificity of prostate cancer screening. JAMA 1995, 274:1214\u20131220.","journal-title":"JAMA"},{"key":"29_CR13","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/S0022-5347(01)65847-6","volume":"156","author":"AF Prestigiacomo","year":"1995","unstructured":"Prestigiacomo AF, Lilja H, Pettersson K, et al.: A comparison of the \u2018free\u201d fraction of serum prostate-specific antigen (PSA) in men with benign and cancerous prostates. J Urol 1995, 156:350\u2013354.","journal-title":"J Urol"},{"key":"29_CR14","first-page":"370A","volume":"155","author":"A Reissigl","year":"1996","unstructured":"Reissigl A, Klocker H, Pointer J, et al.: Improvement of prostate cancer (PCA) screening by determination of the ratio free\/ total (f\/t) PSA in addition to PSA levels: a prospective study. J Urol 1996, 155:370A.","journal-title":"J Urol"},{"key":"29_CR15","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/S0094-0143(05)70382-7","volume":"24","author":"PA Abrahamsson","year":"1997","unstructured":"Abrahamsson PA, Lilja H, Oesterling JE: Molecular forms of serum prostate-specific antigen: the clinical value of percent free prostate-specific antigen. Urol Clin North Am 1997, 24:353\u2013365.","journal-title":"Urol Clin North Am"},{"key":"29_CR16","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/S0022-5347(17)35408-3","volume":"150","author":"A Christensson","year":"1993","unstructured":"Christensson A, Bjork T, Nilsson O, et al.: Serum prostate-specific antigen complexed to alpha-1-antichymotrypsin as an indicator of prostate cancer. J Urol 1993, 150:100\u2013105.","journal-title":"J Urol"},{"key":"29_CR17","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1111\/j.1464-410X.2004.04899.x","volume":"94","author":"JK Parsons","year":"2004","unstructured":"Parsons JK, Brawer MK, Cheli CD, et al.: Complexed prostate specific antigen (PSA) reduces unnecessary prostate biopsies in the 2.6\u20134.0 ng\/mL range of total PSA. BJU Int 2004, 94:47\u201350.","journal-title":"BJU Int"},{"key":"29_CR18","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/0090-4295(89)90131-3","volume":"33","author":"DL Dalton","year":"1989","unstructured":"Dalton DL: Elevated serum prostate-specific antigen due to acute bacterial prostatitis. Urology 1989, 33:465.","journal-title":"Urology"},{"key":"29_CR19","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1159\/000474140","volume":"30","author":"V Pansadoro","year":"1996","unstructured":"Pansadoro V, Emiliozzi P, Defidio L, et al.: Prostate-specific antigen and prostatitis in men under fifty. Eur Urol 1996, 30:24\u201327.","journal-title":"Eur Urol"},{"key":"29_CR20","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1002\/pros.2990200206","volume":"20","author":"TD Moon","year":"1992","unstructured":"Moon TD, Clejan S, Neal DE Jr: Prostate-specific antigen and prostatitis II: PSA production and release kinetics in vitro. Prostate 1992, 20:113\u2013116.","journal-title":"Prostate"},{"key":"29_CR21","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1002\/pros.2990250206","volume":"25","author":"Y Hasui","year":"1994","unstructured":"Hasui Y, Marutsuka K, Asada Y, et al.: Relationship between serum prostate-specific antigen and histological prostatitis in patients with benign prostatic hyperplasia. Prostate 1994, 25:91\u201396.","journal-title":"Prostate"},{"key":"29_CR22","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1097\/00000478-200010000-00007","volume":"24","author":"RA Milord","year":"2000","unstructured":"Milord RA, Kahane H, Epstein JI: Infarct of the prostate gland: experience on needle biopsy specimens. Am J Surg Pathol 2000, 24:1378\u20131384.","journal-title":"Am J Surg Pathol"},{"key":"29_CR23","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/S0302-2838(03)00158-1","volume":"43","author":"X Game","year":"2003","unstructured":"Game X, Vincendeau S, Palascak R, et al.: Total and free serum prostate-specific antigen levels during the first month of acute prostatitis. Eur Urol 2003, 43:702\u2013705. This article presents the effect of acute prostatitis on total and free serum PSA levels in patients treated with antibiotics.","journal-title":"Eur Urol"},{"key":"29_CR24","first-page":"445","volume":"39","author":"M Yamamoto","year":"1993","unstructured":"Yamamoto M, Hibi H, Miyake K: Prostate-specific antigen levels in acute and chronic bacterial prostatitis. Hinyokika Kiyo 1993, 39:445\u2013449.","journal-title":"Hinyokika Kiyo"},{"key":"29_CR25","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1016\/S0022-5347(01)64957-7","volume":"157","author":"J Irani","year":"1997","unstructured":"Irani J, Levillain P, Goujon JM, et al.: Inflammation in benign prostatic hyperplasia: correlation with prostate-specific antigen value. J Urol 1997, 157:1301\u20131303.","journal-title":"J Urol"},{"key":"29_CR26","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1111\/j.1464-410X.2004.04642.x","volume":"93","author":"S Kravchick","year":"2004","unstructured":"Kravchick S, Cytron S, Agulansky L, Ben-Dor D: Acute prostatitis in middle-aged men: a prospective study. BJU Int 2004, 93:93\u201396.","journal-title":"BJU Int"},{"key":"29_CR27","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1016\/S0022-5347(17)38098-9","volume":"146","author":"RR Bahnson","year":"1991","unstructured":"Bahnson RR: Elevation of prostate-specific antigen from bacillus Calmette-Guerin-induced granulomatous prostatitis. J Urol 1991, 146:1368\u20131369.","journal-title":"J Urol"},{"key":"29_CR28","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1016\/S0022-5347(05)67025-5","volume":"164","author":"D Leibovici","year":"2000","unstructured":"Leibovici D, Zisman A, Chen-Levyi Z, et al.: Elevated prostatespecific antigen serum levels after intravesical instillation of bacillus Calmette-Guerin. J Urol 2000, 164:1546\u20131549.","journal-title":"J Urol"},{"key":"29_CR29","first-page":"2407","volume":"154","author":"RB Nadler","year":"1995","unstructured":"Nadler RB, Humphrey PA, Smith DS, et al.: Effect of inflammation and benign prostatic hyperplasia on elevated serum prostate specific antigen levels. J Urol 1995, 154:2407\u20132413.","journal-title":"J Urol"},{"key":"29_CR30","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1177\/172460080201700202","volume":"17","author":"JA Lorente","year":"2002","unstructured":"Lorente JA, Arango O, Bielsa O, et al.: Effect of antibiotic treatment on serum PSA and percent free PSA levels in patients with biochemical criteria for prostate biopsy and previous lower urinary tract infections. Int J Biol Markers 2002, 17:84\u201389.","journal-title":"Int J Biol Markers"},{"key":"29_CR31","first-page":"425A","volume":"155","author":"MB Tchetgen","year":"1996","unstructured":"Tchetgen MB, Wojno KJ, Oesterling JE, et al.: The effect of short course of antibiotics on serum PSA concentration. J Urol 1996, 155:425A. This article shows that in patients with a low AUA symptom score, the yield biopsy was higher. A high AUA symptom score, being a proxy marker for BPH or inflammation, actually decreased the risk of finding underlying cancer.","journal-title":"J Urol"},{"key":"29_CR32","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.urology.2003.08.019","volume":"63","author":"CR Porter","year":"2004","unstructured":"Porter CR, Kim J: Low AUA symptom score independently predicts positive prostate needle biopsy: results from a racially diverse series of 411 patients. Urology 2004, 63:90\u201394.","journal-title":"Urology"},{"key":"29_CR33","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1159\/000052500","volume":"39","author":"G Karazanashvili","year":"2001","unstructured":"Karazanashvili G, Managadze L: Prostate-specific antigen (PSA) value change after antibacterial therapy of prostate inflammation, as a diagnostic method for prostate cancer screening in cases of PSA value within 4\u201310 ng\/mL and nonsuspicious results of digital rectal examination. Eur Urol 2001, 39:538\u2013543. Quantification of PSA drop as percent PSA value changes was studied and it correlated well with a higher positive biopsy yield in patients with a lower PSA value change.","journal-title":"Eur Urol"},{"key":"29_CR34","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1016\/S0022-5347(05)65186-5","volume":"167","author":"CB Bozeman","year":"2002","unstructured":"Bozeman CB, Carver BS, Eastham JA, Venable DD: Treatment of chronic prostatitis lowers serum prostate-specific antigen. J Urol 2002, 167:1723\u20131726. Institutional experience showing that PSA normalization after a course of antibiotic treatment in patients with prostatitis can decrease the number of negative prostatic biopsies.","journal-title":"J Urol"},{"key":"29_CR35","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1016\/S0022-5347(05)67026-7","volume":"164","author":"JM Potts","year":"2000","unstructured":"Potts JM: Prospective identification of National Institutes of Health category-IV prostatitis in men with elevated prostate specific antigen. J Urol 2000, 164:1550\u20131553.","journal-title":"J Urol"},{"key":"29_CR36","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1002\/1097-0045(20000615)44:1<49::AID-PROS7>3.0.CO;2-7","volume":"44","author":"S Ponniah","year":"2000","unstructured":"Ponniah S, Arah I, Alexander RB: PSA is a candidate self-antigen in autoimmune chronic prostatitis\/chronic pelvic pain syndrome. Prostate 2000, 44:49\u201354.","journal-title":"Prostate"},{"key":"29_CR37","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1097\/00005392-199805000-00050","volume":"159","author":"K Jung","year":"1998","unstructured":"Jung K, Meyer A, Lein M, et al.: Ratio of free-to-total prostate specific antigen in serum cannot distinguish patients with prostate cancer from those with chronic inflammation of the prostate. J Urol 1998, 159:1595\u20131598.","journal-title":"J Urol"},{"key":"29_CR38","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1097\/01.ju.0000081650.23715.4c","volume":"170","author":"SE Lee","year":"2003","unstructured":"Lee SE, Ku JH, Park HK, et al.: Prostatic calculi do not influence the level of serum prostate-specific antigen in men without clinically detectable prostate cancer or prostatitis. J Urol 2003, 170:745\u2013748.","journal-title":"J Urol"},{"key":"29_CR39","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/S0022-5347(05)63959-6","volume":"169","author":"BS Carver","year":"2003","unstructured":"Carver BS, Bozeman CB, Williams BJ, Venable DD: The prevalence of men with National Institutes of Health category IV prostatitis and association with serum prostate-specific antigen. J Urol 2003, 169:589\u2013591. Our institutional experience in men with asymptomatic prostatitis detected during routine screening showed higher PSA levels in the presence of inflammation compared with ones with negative EPS.","journal-title":"J Urol"},{"key":"29_CR40","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1016\/S0090-4295(00)00519-7","volume":"55","author":"K Okada","year":"2000","unstructured":"Okada K, Kojima M, Naya Y, et al.: Correlation of histological inflammation in needle biopsy specimens with serum prostate-specific antigen levels in men with negative biopsy for prostate cancer. Urology 2000, 55:892\u2013898.","journal-title":"Urology"},{"key":"29_CR41","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1159\/000020190","volume":"37","author":"J Morote","year":"2000","unstructured":"Morote J, Lopez M, Encabo G, de Torres IM: Effect of inflammation and benign prostatic enlargement on total and percent free serum prostatic specific antigen. Eur Urol 2000, 37:537\u2013540.","journal-title":"Eur Urol"},{"key":"29_CR42","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/S0022-5347(17)56980-3","volume":"121","author":"PW Kohnen","year":"1979","unstructured":"Kohnen PW, Drach GW: Patterns of inflammation in prostatic hyperplasia: a histologic and bacteriologic study. J Urol 1979, 121:755\u2013760.","journal-title":"J Urol"},{"key":"29_CR43","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1016\/j.eururo.2004.08.003","volume":"46","author":"I Stancik","year":"2004","unstructured":"Stancik I, Luftenegger W, Klimpfinger M, et al.: Effect of NIH-IV prostatitis on free and free-to-total PSA. Eur Urol 2004, 46:760\u2013764.","journal-title":"Eur Urol"},{"key":"29_CR44","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1016\/S0090-4295(03)00688-5","volume":"62","author":"C Kwak","year":"2003","unstructured":"Kwak C, Ku JH, Kim T, et al.: Effect of subclinical prostatic inflammation on serum PSA levels in men with clinically undetectable prostate cancer. Urology 2003, 62:854\u2013859.","journal-title":"Urology"},{"key":"29_CR45","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1159\/000071839","volume":"71","author":"O Yaman","year":"2003","unstructured":"Yaman O, Gogus C, Tulunay O, et al.: Increased prostate-specific antigen in subclinical prostatitis: the role of aggressiveness and extension of inflammation. Urol Int 2003, 71:160\u2013164. Study showing that it is not the presence or absence, but the aggressiveness of inflammation that correlated with PSA levels.","journal-title":"Urol Int"},{"key":"29_CR46","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1159\/000020161","volume":"37","author":"PH Schatteman","year":"2000","unstructured":"Schatteman PH, Hoekx L, Wyndaele JJ, et al.: Inflammation in prostate biopsies of men without prostatic malignancy or clinical prostatitis: correlation with total serum PSA and PSA density. Eur Urol 2000, 37:404\u2013412.","journal-title":"Eur Urol"},{"key":"29_CR47","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/S0889-8588(05)70223-9","volume":"15","author":"MJ Putzi","year":"2001","unstructured":"Putzi MJ, De Marzo AM: Prostate pathology: histologic and molecular perspectives. Hematol Oncol Clin North Am 2001, 15:407\u2013421.","journal-title":"Hematol Oncol Clin North Am"},{"key":"29_CR48","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1073\/pnas.91.4.1261","volume":"91","author":"SA Weitzman","year":"1994","unstructured":"Weitzman SA, Turk PW, Milkowski DH, Kozlowski K: Free radical adducts induce alterations in DNA cytosine methylation. Proc Natl Acad Sci U S A 1994, 91:1261\u20131264.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"29_CR49","first-page":"671","volume":"43","author":"S Gupta","year":"2002","unstructured":"Gupta S, Adhami VM, Lewin JS, Mukhtar H: Dietary supplementation of selective COX-2 inhibitor celecoxib suppresses prostate carcinogenesis in TRAMP mice. Proc Am Assoc Cancer Res 2002, 43:671.","journal-title":"Proc Am Assoc Cancer Res"},{"key":"29_CR50","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/S0090-4295(99)00152-1","volume":"54","author":"J Irani","year":"1999","unstructured":"Irani J, Goujon JM, Ragni E, et al.: High-grade inflammation in prostate cancer as a prognostic factor for biochemical recurrence after radical prostatectomy. Pathologist Multi Center Study Group. Urology 1999, 54:467\u2013472.","journal-title":"Urology"}],"container-title":["Current Urology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11934-005-0029-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11934-005-0029-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11934-005-0029-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11934-005-0029-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,15]],"date-time":"2022-05-15T11:58:34Z","timestamp":1652615914000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11934-005-0029-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,8]]},"references-count":50,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2005,8]]}},"alternative-id":["29"],"URL":"https:\/\/doi.org\/10.1007\/s11934-005-0029-y","relation":{},"ISSN":["1527-2737","1534-6285"],"issn-type":[{"value":"1527-2737","type":"print"},{"value":"1534-6285","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,8]]}}}